piracetam has been researched along with Arteriosclerosis in 3 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lloyd-Evans, S | 2 |
| Brocklehurst, JC | 2 |
| Palmer, MK | 2 |
| Nikitin, AV | 1 |
| Chesnokova, IV | 1 |
| Sysoeva, LI | 1 |
2 trials available for piracetam and Arteriosclerosis
| Article | Year |
|---|---|
Assessment of drug therapy in chronic brain failure.
Topics: Activities of Daily Living; Aged; Arteriosclerosis; Clinical Trials as Topic; Dementia; Double-Blind | 1978 |
Piracetam in chronic brain failure.
Topics: Arteriosclerosis; Chronic Disease; Dementia; Double-Blind Method; Female; Humans; Male; Piracetam; P | 1979 |
1 other study available for piracetam and Arteriosclerosis
| Article | Year |
|---|---|
[The efficacy of piracetam in treating patients with chronic bronchitis and concomitant atherosclerosis].
Topics: Aged; Arteriosclerosis; Bronchitis; Chronic Disease; Drug Evaluation; Humans; Lipid Peroxidation; Mi | 1990 |